Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
TBPH logo

TBPH

NSD
Theravance Biopharma Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Monday 14th July 2025
11.30
-0.16 (-1.40%)
Prev Close:11.46
Open:11.41
Bid:10.7
Ask:11.5
52 Week Range
7.44
11.82
Volume:275,909
Mkt Cap:561 M
Price Target
$12.99
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

TBPH - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Acquisition Expense60 M
Allowances For Construction62 M
Basic Discontinuous Operations13.11
Depreciation And Amortization2 M2 M3 M4 M3 M3 M-3 M-2 M-2 M-2 M
Development Expense63 M
Diluted Discontinuous Operations13.11
Earnings From Equity Interest104 M68 M34 M11 M170000.0
Earnings From Equity Interest Net Of Tax104 M68 M34 M11 M170000.0
Gain On Sale Of Business6 M
Gain On Sale Of PPE1 M
Gain On Sale Of Security8 M-8 M
Gains Loss On Disposal Of Discontinued Operations-179 M
General And Administrative Expense69 M70 M67 M99 M109 M106 M
Gross Profit Margin (profit Margin After CGS)64 M57 M51 M55 M72 M73 M60 M15 M46 M37 M
Interest Expense Non Operating2 M6 M9 M9 M32 M10 M9 M1 M
Misc Other Special Charges5 M9 M6 M1 M-13 M8 M12 M5 M1 M631000.0
Net Income (loss)-56 M-55 M872 M-199 M-278 M-236 M-267 M-335 M-232 M-236 M
Net Income Common Stockholders-56 M-55 M872 M-199 M-278 M-297 M-267 M-335 M-232 M-236 M
Net Income Continuous Operations-56 M-55 M-93 M-199 M-278 M-236 M-267 M-335 M-232 M-236 M
Net Income Discontinuous Operations1,930 M66 M
Net Non Operating Interest Income Expense-7 M-2 M-9 M-45 M-32 M-10 M-9 M-1 M
Normalized Income-40 M-245 M
Operating Income-47 M-56 M-92 M-258 M-298 M-252 M-290 M-309 M-222 M-236 M
Operating Income Before Depreciation (EBITDA)-41 M-45 M-79 M-248 M-288 M-204 M-212 M-259 M-176 M-178 M
Operating Expense111 M113 M143 M313 M370 M325 M-299 M-276 M-229 M-224 M
Other Gain Loss From Disposition Of Discontinued Operations2,109 M66 M
Other Gand A69 M70 M67 M99 M109 M106 M
Other Impairment Of Capital Assets5 M
Other Operating Expenses-4 M-4 M143 M-12 M-13 M-8 M715000.06 M-229 M-224 M
Other Write Off40 M63 M60 M
Promotion And Advertising4 M5 M8 M9 M6 M2 M-2 M-3 M-2 M-4 M
Research Expense38 M41 M63 M194 M261 M219 M201 M174 M142 M129 M
Restructring And Mn A Income3 M13 M20 M4 M
Salaries And Wages21 M25 M2 M3 M51 M49 M41 M54 M
Selling And Marketing Expense4 M5 M8 M9 M6 M2 M97 M96 M85 M90 M
Selling Expense62 M97 M96 M85 M90 M
Total Income Available For Interest Expense (EBIT)-45 M-49 M-86 M-257 M-295 M-210 M-216 M-263 M-179 M-181 M
Total Revenues64 M57 M51 M55 M72 M73 M60 M15 M49 M42 M
Total Expenses111 M113 M137 M313 M370 M325 M-299 M-276 M-232 M-229 M
Total Revenue64 M57 M51 M55 M72 M73 M60 M15 M18 M9 M
Write Down8 M
Amord536000.01 M2 M3 M-1 M-1 M
Avgshs49 M55 M74 M69 M62 M56 M54 M52 M45 M34 M
Avgshsdt49 M55 M74 M69 M62 M56 M54 M61 M54 M44 M
Basiceps-1.15-1.023.7-2.87-4.46-4.25
Basicepscont-1.15-2.010.59-2.87-4.46-4.25
Cor-6 M-3 M-5 M
Depamor2 M2 M3 M4 M3 M3 M-3 M-2 M-2 M-2 M
Dileps-1.15-1.023.7-2.87-4.46-4.25-3.99-5.45-4.26-5.34
Dilepscont-1.15-2.010.59-2.87
Netincdisc-56 M-55 M872 M-199 M-278 M-236 M-267 M-335 M-232 M-236 M
Othincexp-368000.0-9 M-9 M61 M7 M-42 M-23 M-5 M-1 M-631000.0
Pretaxinc-45 M-49 M-93 M-265 M-287 M-242 M-226 M-272 M-181 M-181 M
Resdev38 M41 M63 M194 M261 M219 M201 M174 M142 M129 M
Restruct3 M13 M20 M4 M
Sga69 M70 M67 M99 M109 M106 M97 M96 M85 M90 M
Shsout49 M48 M63 M75 M64 M63 M56 M54 M53 M38 M
Specincchg-3 M-13 M-20 M-3 M-8 M
Taxprov12 M6 M9000.0-151000.0-9 M-5 M-11 M14 M10 M951000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader